Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 2

1.

Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.

Kikkert WJ, Claessen BE, Stone GW, Mehran R, Witzenbichler B, Brodie BR, Wöhrle J, Witkowski A, Guagliumi G, Zmudka K, Henriques JP, Tijssen JG, Sanidas EA, Chantziara V, Xu K, Dangas GD.

J Thromb Thrombolysis. 2013 Feb;35(2):200-8. doi: 10.1007/s11239-012-0837-0.

PMID:
23212802
2.

Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis.

Kikkert WJ, Delewi R, Ouweneel DM, van Nes SH, Vis MM, Baan J Jr, Koch KT, Dangas GD, Mehran R, de Winter RJ, Peters RJ, Piek JJ, Tijssen JG, Henriques JP.

JACC Cardiovasc Interv. 2014 Jun;7(6):622-30. doi: 10.1016/j.jcin.2014.01.162. Epub 2014 May 14. Review.

Supplemental Content

Support Center